A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus

NCT06937203 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Diabetes Mellitus, Type 2

Interventions

DRUG: ARO-ALK7
DRUG: Placebo

Sponsor

Arrowhead Pharmaceuticals